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Summary : Morphogenesis of micromegakaryocytes in MDS was investigated in a 
case of refractory anemia with excess of blasts by analysing megakaryocyte colonies 
developed from peripheral blood mononuclear cells in a semi-solid culture containing 
aplastic anemia patient's plasma as source for megakaryocyte colony stimulating factor 
and thrombopoiesis stimulationg factor. Candidate megakaryocyte colonies were 
individually stained for glycoprotein (GP)IIb/IIIa by immunocytochemical method. Three 
types of colonies were distinguished ; type I composed of 10-30 large magakaryocytes with 
high ploidy number, type II composed of 50-200 micromegakaryocytes with single nucleus, 
and type III composed of 20-50 micromegakaryocytes. Type I colonies were similar to 
megakaryocyte colonies obtained from three control subjects. Periodic in situ observation 
of type II and III colonies disclosed that large megakaryocytes never appeared during 
21 days' culture, suggesting mitotic growth at every generation. These findings indicate 
that loss of endoreduplication is primary defect in micromegakaryocyte formation by MDS 
clone. Quantitaive aspect of platelet formation by micromegakaryocytes could not be 
assessed in this study, but morphological observation in situ or on GPIIb/IIIa-stained 
preparation suggested reduced platelet production. Biological significance of diminished 
endoreduplication is yet to be determined in respect to leukemic predisposition.
       INTRODUCTION 
 Dysmegakaryocytopoiesis is one of the mor-
phological dysplastic changes on which diag-
nosis of myelodysplastic syndromes (MDS) is 
based'). Micromegakaryocytes, multi-separat-
ed-nuclear megakaryocytes and mononuclear 
megakaryocytes are considered pathologic. 
Refractory anaemia with an excess of blasts 
(RAEB)2) and refractory anaemia (RA) with 
5q-anomaly3> characteristically manifest micro-
megakaryocytes. 
 Morphogenesis of micromegakaryocytes and
their pathologic significance in terms of 
leukemic predisposition are not well understood. 
The present study was conducted to obtain from 
a RAEB patient micromegakaryocyte colonies 
in semi-solid culture in order to analyse how 
micromegakaryocytes are produced in vitro.
MATERIALS AND METHODS
1. Patient and Control Subjects 
 A 42-year-old male was admitted for furth 
evaluation of pancytopenia. Hematological da 
on admission were as follows : Hb 9.2g/dl, WE 





86%, monocytes 1%, blasts 2%, platelets 117X 
109/l. Bone marrow was hypercellular with 10% 
blasts and myeloid/erythroid ratio of 0.86. 
Ringed sideroblasts . were absent. Typical 
pseudo-Pelger-Huet anomaly, multi-nuclear 
erythroblasts, micromegakaryocytes and multi-
separated nuclear megakaryocytes were abun-
dant. A diagnosis of RAEB was established. 
 The patient was administerred subcutane-
ously low dose of cytosine arabinoside (ara-C) 
for 14 days ; 16mg/day for 8 days and 32mg/day 
for 6 days. The bone marrow became dry tap 
on aspiration during this treatment. Jamshidi's 
needle biopsy proved moderate myelofibrosis. 
Around three weeks after the cessation of ara-C 
peripheral blood hematopoiesis began to recover 
gradually. He was then treated with vitamin 
D3 (3,ug/day) for three months. Hb value reached 
13.5 g/dl, neutrophi count 2.5X 109/l and platelet 
280 X 109/l. The bone marrow could be aspirated 
again. Cell morphology was still abnormal but 
less dysplatic than that of the initial marrow. 
Micromegakaryocytes were greatly decreased in 
number but multi-separated or mono-nuclear 
megakaryocytes remained. Initial mega-
karyocyte-colony formation was performed 
during this clinical remission. 
 After three months of almost full recovery in 
hematopoiesis, pancytopenia gradually devel-
oped and the bone marrow became dry tap 
again. Peripheral blood leukocyte analysis 
disclosed an increased number of blasts which 
were myeloperoxidase negative, 10% My 7 (CD 
13) positive and 1% GPIIB/IIIa positive. The 
second megakaryocyte-colony formation was 
done on this periopheral blood mononuclear 
cells. In spite of the second course of low dose 
ara-C, leukemic manifestation became apparent 
with blast increase up to 40%. The patient died 
of cerebral hemorrhage. 
 For control experiments three normal subjects 
were studied. Bone marrow mononuclear cells 
were obtained from a 25-year-old male and 
peripheral blood mononuclear cells from 25-
year-old and 23-year-old females. 
 All samples were obtained with informed 
consents. 
2. Megakaryocyte-Colony Formation 
 Mononuclear cells (MNC) were separated from
peripheral blood or bone marrow by Ficoll-
Hypaque gradient density centrifugation. 2 to 
3 X 105 MNC were plated in lml of Iscove's 
modified Dulbecco's medium (MDM) containing 
0.88% methylcellulose, 30% aplastic anaemia 
patients's plasma and 5 X 10-5 M 2-mercap-
toethanol and cultured at 37°C in a humidified 
atmosphere with 5% CO2 in air. Wells were 
observed for cluster or colony formation every 
three days during 21 days' culture. 
3. Glycoprotein IIb/IIIa Staining of Individual 
Colonies by Immuno-cytochemical Method 
 Candidate colonies of unique morphology 
suggestive of megakaryocytic lineage were 
individually aspirated by a finely drawn out 
capillary tube and mixed with 10,u1 of Iscove's 
MDM placed on a poly-L-lysine-coated slide. 
After 15 min standing overlayer medium was 
discarded by absorbant paper. The slide was 
air-dried rapidly and fixed for 90 min 4'C with 
10% formain-80% acetone mixture. 
 After washing with O.1M phosphate buffered 
saline (PBS) cell fixed area of the slide 
(approximately 3 mm in diameter) was covered 
with optimally diluted monoclonal antibody (P2, 
Immunotech, Marselle) for platelet glycoprotein 
(GP) IIb/IIIa (CDw41) and incubated for 60 
minutes at from temperature in a wet chamber. 
The slide was then thoroughly washed with PBS 
for three minutes and covered with link-
antibody (biotinylated anti-mouse immuno-
globulin antibody ; Biotin-Streptoavidin 
Stravigen Immunostaining Kit, Biogenex Lab., 
California), followed by incubation at 37CC in 
a wet chamber for 15 min. The slide was then 
washed with PBS for three minutes and covered 
with enzyme-conjugate (streptoavidin-alkaline 
phosphatase) and incubated at 37'C in a wet 
chamber for 15 min. After final washing with 
PBS for three minutes the slide was subjected 
to alkaline phosphatase stain by azo-dye 
method. The slide was mounted with glycerine 
gelatin (Merck).
          RESULTS 
1. Megakaryocyte-Colony Formation in Normal 
Subjects 
 As shown in Table 1 all samples from three
            Table 1. Megakaryocyte Colony Formation in Normal Subjects 
Subject No. Cell source Candidate Meg-Colony GPIIb/IIIa positive colony o                        t
ype and No./2 X 10' MNC (concordance /o)                                                    colony examined 
  1. bone marrow I 24±2 10/10 (100) 
                     II 0 
                     III 0
  2. peripheral blood I 20±2 10/10 (100) 
                      II 0 
                     III 0
  3. peripheral blood 1 2±1 5/5 (100) 
                     II 0 
                     III 0
Fig. 1. A megakaryocyte colony of type I developed 
      from normal subject's pheripheral blood 
      mononuclear cells in methylcellulose cul-
      ture containing aplastic anemia patient's
      plasma. Colony composing cells have 
       generally large size, transluscent cytoplasm
      and abundant pariticulate materials on 
      their cell margin (x 100).
Fig. 2. A micromegakaryocyte colony of type II 
      developed from peripheral blood mononu-
      clear cells of RAEB case. Colony composing 
      cells have generally small size equivalent 
       to those in granulocyte-macrophage colo-
       nies, transluscent cytoplasm but no 
      particulate materials on their cell margin
     (x 100).
controls developed type I megakaryocyte-
colonies. Colony number was counted on day 
21. Most of them were composed of 10 to 30 
cells. Two third of them showed extremely large 
sizes and transluscent cytoplasm with many 
particulate materials on their cell margin (Fig. 
1). Individual colonies were aspirated and 
stained for GPIIb/IIIa. 100% concordance was 
noted between in-situ determined mega-
karyocyte-colonies and GPIIb/IIIa positive 
colonies. 
2. Megakaryocyte-Colony Formation in RAEB
Case 
(a) From Peripheral Blood MNC on Relapse 
 As shown in Table 2, there formed three types 
of in situ determined megakaryocyte-colonies. 
Type I is very similar to normal mega-
karyocyte-colonies composed of 10-30 cells 
containing large cells. GPIIb/IIIa stain revealed 
that type I colonies examined were all 
megakaryocytic. Type II was composed of 50-
200 cells most of which were small cells (Fig. 
2). Particarlate materials were never formed on 
their cellular margin. GPIIb/IIIa stain showed 
that 80% of these colonies examined were
   Table 2. Megakaryocyte and Other Haematopoietic Colony Formation in RAEB Case 
  Cell source Colony type Colony No./3X10'MNC GPIIb/IIIa positive colony (concordance %) 
                                                   colony examined 
Peripheral blood Candidate 
   on relapse Meg-colony 
               I 37 7/7 (100) 
               II 24 8/10 ( 80)
               III 40 9/10 ( 80)
               BFU-E 15 0/5 ( 0)
              CFU-GM 7 0/4 ( 0)
  Bone marrow Candidate 
  on remission Meg-colony 
                       I 5 n. e. 
                II 0 
               III 0
                   BFU-E 25 n. e. 
                 CFU-GM 22 n. e.
n. e. not examined
   Table 3. Morphological Analysis of Megakaryocyte Colony Composing Cells 
    C Colony No. Colony No. Colony No. with nuclear ploidy No.     ase Colony type 
examined examined                                        1 2 2< 
   RAEB 1 7 75 0 0 75 
                II 8 420 411 9 0
                III 9 125 120 5 0
Normal Subject 
    No.1 1 10 68 0 0 68
Fig. 3. GPIIb/IIIa-stained megakaryocytes of type 
      I (Fig. 1) showing diffuse cytoplasmic
      positivity and high nuclear ploidy number 
     (x 1000).
Fig 4. GPIIb/IIIa-stained micromegakaryocyrtes 
      of type II colony (Fig. 2) showing diffuse 
       positivity and mononuclear or rarely 
      binuclear configuration (X1000).
positive for magakaryocyte-specific antigen. 
Type III was smaller than type II, containing 
20-50 small cells. 90% of these colonies examined
were GPIIb/IIIa positive. Erythroid bursts and 
granulocyte/macrophage colonies were also 
formed in the same dish. Some of these colonies
were examined for GPIIb/IIIa ; all being 
negative. 
(b) From Bone Marrow MNC on Clinical Remis-
sion 
 GM-colonies and erythroid bursts were 
formed fairly well with recombinant GM-CSF 
and erythropoietion respectively. A few maga-
karyocyte-colonies of type I were formed when 
stimulated by aplastic anaemia plasma. Type 
II and III colonies were absent. 
3. Morphological Analysis of Colony-Composing 
Cells on GPIIb/IIIa-Stained Slides 
 As shown in Table 3, normal colonies were 
composed of large (over 50u) cells with 
multilobulated nuclei (Fig. 3). Type I colonies 
from RAEB case showed a similart pattern. 
Type II and III colonies were composed of small 
(15-30,u) cells with mostly single nucleus or rarely 
two separate nuclei (Fig. 4). All megakaryocytes, 
regardless of colony types, showed strong 
diffuse cytoplasmic stain for GPIIb/IIIa.
         DISCUSSION 
 By employing semi-solid culture stimulated 
by aplastic anemia plasma which is supposed 
to contain megakaryocyte-colony stimulating 
factor (Meg-CSF) and thrombopoiesisstimulat-
ing factor (TSF) according to Hoffman et al'), 
we could observe atypical magakaryocyte 
colonies composed of apparent GPIIb/iiia 
positive micromegakaryocytes. Most of them 
possessed single nucleus or rarely two nuclei. 
Periodic in situ observation during 21 days' 
culture disclosed that large cells equivalent to 
those appearing around day 10 in normal 
megakaryocyte colonies or type I colonies of 
RAEB never appeared among uniformaly 
small-sized cells of type II and III colonies. 
Maximum number of colony (type II) composing 
cells reached 200 cells, indicating more than 
seven mitotic generations. This means that 
micromegakaryocytes were produced in vitro 
only by mitosis of precursor cells at every 
generation. Therefore, it is conceivable that loss 
of physiological endoreduplication is a primary 
defect in micromegakaryocyte formation by 
RAEB clone.
 Although the mechanism of endoreduplica-
tion is not yet fully understood, experimental 
evidences suggest that it is controlled by soluble 
factors such as Meg-CEF or TSF6). These 
factors are known to be increased in con-
certraion in vivo when megakaryocyte number 
or platelet count is reduced. Arriaga et al 
recently suggested reciplocal interrelationship 
between mitosis and endoreduplication by 
magakaryocyte progenitors6). In their experi-
ment using aplastic canine serum as a source 
Meg-CSF, its lower concentation enhanced both 
mitosis and endoreduplication while higher 
concentration increased mitosis further but 
markedly reduced megakaryocyte ploidy 
number. In our culture condition employing 
high concertration of aplastic anaemia plasma, 
most of the normal megakaryocyte colonies were 
apparently composed of large cells with 
considerablly high ploidy number. Therefore, 
the production of micromegakaryocytes with 
low ploidy number is not the result of high 
concentration of the plasma added, but most 
likely represents the pathologic megakaryocyto-
poiesis of RAEB clone. It may be interesting 
to further investigate the mechanism of such 
dissociation between mitosis and endo-
reduplication. 
 Our study could not estimate magnitude of 
thrombopoiesis by single micromegakaryocytes. 
However, morphological observation in situ or 
on GPIIb/IIIa-stained preparations showed 
abundant platelets shedding from the cyto-
plasmic rim of large megakaryocytes with high 
ploidy number, but rare shedding from 
micromegakaryocytes in spite of cytoplasmic 
maturation showing strong diffuse staining for 
GPllb/IIIa. This observation suggests reduced 
platelet forming capacity by the latter cells. 
 Biological significance of micromegakaryocyte 
formation in MDS was suggested by Varela et 
al in respect to later leukemic change''. 
However, cases of RA with 5q-anomaly which 
characteristically has abundant microme-
gakaryocytes is regarded to have a lower 
probability of leukemic change compared with 
ordinary RA cases'). Our preliminary analysis 
on cell size showed that micromegakaryocytes 
of 5q-anomaly are much larger than those of 
RAEB. The size of micromegakaryocytes seems
another function of megakaryocyte pathology. 
As shown in our study and others') immu-
nocytochemical staining of platelet specific 
glycoproteins on routine peripheral blood and 
bone marrow preparations of MDS certainly 
facilitates analysis of megakaryocytes ranging 
in size from lymphocyte-equivalent to giant. 
Such analyses will lead to more detailed 
understanding of megakaryocyte pathology in 
AML and MDS.
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